Schultes Birgit C bought NTLA
March 1, 2025 · Form 4 insider transaction
Schultes Birgit C bought 53,714 shares of Intellia Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
53,714
Price
$0.00
Total value
N/A
InsiderSchultes Birgit C
RoleOfficer
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateMarch 1, 2025
Filing dateMarch 4, 2025
Shares owned after53,714
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option was granted on March 1, 2025 with respect to shares of Common Stock, with 33% vesting on January 1, 2026 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter.